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Amphotropic Moloney-murine leukemia virus recombinants (Mo-AmphoV) induce a severe spongiform encephalomyelopathy in
newborn mice. We show here that a coisogenic recombinant with a 10A1-MuLV host range (Mo-10A1V) also induces a
neurodegenerative disease, clinically characterized by mild tremor and ataxia. Spongiform lesions are most severe in the
metencephalon and mesencephalon but extend into the prosencephalon and spinal cord. Significantly, the quality of histopathology
was indistinguishable between Mo-AmphoV and Mo-10A1V, probably reflecting a final common pathogenic pathway. Common
receptor use thus may be an important determinant in the pathogenicity of these viruses. These results have implications for the
clinical use of retroviral pseudotypes that use phosphate transporters for cell entry. © 1998 Academic Press
Moloney-murine leukemia virus (Mo-MuLV) recombi-
nants with an amphotropic host range (Mo-AmphoV) in-
duce a fatal neurodegenerative disease in newborn mice,
characterized by noninflammatory spongiform lesions of
nerve and glial cells and their processes (1). This is in
contrast to ecotropic Mo-MuLV, which is non-neurovirulent.
To determine whether sequences in the env gene that
specify receptor use are critical determinants for the neu-
ropathogenicity, a Mo-MuLV recombinant with a 10A1 host
spectrum was analyzed. Similar to amphotropic MuLVs,
10A1 uses the Pit2 phosphate symporter as a receptor;
however, their expanded host range is attributed to the
additional use of the related Pit1 receptor (2, 3), first iden-
tified as the receptor for the gibbon ape leukemia virus
(GALV) (4). These studies are important, not only to define
the mechanism by which spongiform encephalomyelopa-
thy is induced by MuLVs but also to assess the risk of using
retroviral pseudotypes in human gene therapy protocols.
Mo-10A1V and Mo-AmphoV induce
neurodegeneration with similar kinetics but distinct
clinical symptoms
Recombinant Mo-10A1V and Mo-AmphoV (1, 5), in
which the env and 39 pol sequences of Mo-MuLV have
been substituted with that of either 10A1 or 4070A, re-
spectively, were propagated in SC1 fibroblasts. Newborn
DDD mice were infected intraperitoneally with 2 3 104
CFU. Overt clinical and morphological signs of CNS
disease were monitored in 35 infected mice, and the
incidence and latency of severe clinical symptoms are
presented in Fig. 1. After a mean latency of 164 and 183
days, obvious signs of impaired CNS functions (tremor,
ataxia, dyskinesis, or paraparesis) were observed in 58%
and 72% of the mice infected with Mo-10A1V and Mo-
AmphoV, respectively. By 225 days, .95% of all mice in
both groups displayed clear symptoms of either neuro-
logical disease, leukemia, or both.
Despite the similar kinetics, incidence, and latency of
neurological symptoms, a distinct difference between
the severity and type of neurological deficiencies was
observed between the two groups. Of the Mo-AmphoV-
infected mice that had obvious neurological disturbance,
about half showed severe signs of a complex neurolog-
ical syndrome, including tremor, dyskinetic and dystactic
disturbances, paraparesis, and wasting. The disease
progressed to incontinence and complete tetraparesis
(in some cases, tetraparalysis) and, finally, death of the
animal. In contrast, the most evident signs of central
nervous system (CNS) disease in Mo-10A1V-infected
mice were tremor and ataxia, with paraparesis occurring
only at very late stages in a small proportion of the
animals. Similar results were observed in infected NIH
and 129/SvJae mice (data not shown); although prelimi-
nary, these results confirm that susceptibility to Mo-
10A1V neurodegeneration is not limited to DDD mice.
Although previous studies have shown that both Mo-
10A1V and the wild-type 10A1 induce leukemia in NIH/
Swiss mice (5, 6), no mention of symptoms associated
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with CNS disease was made in these studies or in
earlier studies describing the isolation of the 10A1 virus
(7, 8). This is most likely due to the fact that the neuro-
logical symptoms are often masked by the early onset or
coincident symptoms of hematological neoplasia.
The CNS distribution patterns of spongiform lesions
in infected Mo-10A1V and Mo-AmphoV correlate with
the different clinical symptoms
Histological examination of infected mice confirmed
morphological CNS alterations in both experimental
groups. A minimum of five mice in each group were
analyzed that displayed overt signs of CNS disorder
between 160–180 days postinfection. Typical, noninflam-
matory spongiform lesions were observed in all mice but
tended to be more extensive in Mo-AmphoV-infected
mice (Fig. 2). Both viruses consistently induced more or
less symmetrical spongy alterations of central structures
of the vestibuloauditory system in the metencephalon
and mesencephalon (e.g., vestibular and cochlear nuclei,
inferior cerebellar peduncle, trapezoid body, and lateral
lemniscus and their associated nuclei and inferior col-
liculi). In Mo-AmphoV-infected mice (five of five), the
pathological process extended further medially to nuclei
and fiber tracts belonging to the trigeminal and facial
nerves and to the medial lemniscus and also involved
major parts of the pontine tegmentum, where important
structures of the reticular formation are located (Fig. 2a).
Pons, red nucleus, and mesencephalic tegmental areas,
rostral to the rhombencephalon, were also frequently
affected. In contrast, these anatomical structures were
mostly spared in Mo-10A1V-infected mice (four of five);
instead, severe lesions were found to be predominantly
located in the white and gray matter areas of the med-
ullary center of the cerebellum (Fig. 2b). Lesioning of the
rhombencephalic segment of the corticospinal tract oc-
curred more frequently in Mo-AmphoV infections.
Rostral and caudal to the mesencephalon and meten-
cephalon, the spongiform lesions gradually decreased in
both Mo-AmphoV- and Mo-10A1V-infected mice, al-
though circumscribed foci of vacuolated tissue were
always present in prosencephalic centers as well as in
parts of the spinal cord. Significantly, the topographical
lesion distribution changed with the different levels of the
spinal cord, thus implying that systematic degeneration
of distinct sensorimotor systems did not occur. As ob-
served at other CNS levels, spinal cord lesions were
more severe in Mo-AmphoV-infected than in Mo-10A1V-
infected mice.
The different topography of the lesions generally in-
duced by the two recombinants probably accounts for
the distinct clinical lesions observed. Paralysis, hyperki-
nesis and dyskinesis, and wasting syndrome induced by
Mo-AmphoV infection could be explained, respectively,
by damage to the red nucleus, pyramidal tract, and re-
ticular formation. The latter, with its multiple and diffuse
interconnections, plays a dominant role in the subcorti-
cal regulation and modification of autonomic and senso-
rimotor systems, as well as in sensory functions and
behavioral states (9, 10). The predominately cerebellar
lesions of Mo-10A1V infections are compatible with the
prevailing symptoms of tremor and ataxia.
The difference in disease topology in Mo-10A1V and
Mo-AmphoV probably reflects the ability of Mo-10A1V to
use both Pit1 and Pit2 as a cellular receptor, in contrast
to Mo-AmphoV, which uses only Pit2. Although assays
with NIH 3T3 cells indicate that 10A1 recombinants use
the Pit1 and Pit2 receptor with comparable frequencies
(11), Pit1 may be used preferentially by Mo-10A1V in the
CNS, perhaps due to altered processing of either Pit1 or
Pit2. Differential use of Pit1 in human cells by 10A1 has
been previously described (11), and it is known that
post-translation processing, such as glycosylation, can
alter the ability of the protein to act as a receptor (3, 12,
13).
Histopathological alterations are indistinguishable
between Mo-10A1V- and Mo-AmphoV-infected mice
Although the topology of the spongiform lesions varied
between the two recombinant viruses, histopathological
examination revealed strikingly similar cytopathology in
lesions induced by the two virus types. Severe vacuol-
ization of neuronal cell bodies and processes, neuronal
FIG. 1. Latency and cumulative incidence of overt clinical symptoms
is similar in DDD mice infected with either Mo-10A1V or Mo-AmphoV.
The incidence of clinical symptoms, due to spongiform encephalomy-
elopathy, leukemia, or both, were plotted as a function of time after
infection. The cumulative percentage of diseased mice that displayed
clinical symptoms attributable to degenerative CNS disease was 58%
for Mo-10A1V-infected and 72% for Mo-AmphoV-infected mice. SE in-
dicates spongiform encephalomyelopathy.
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loss, and some degree of myelin loss were typically
observed in the absence of inflammatory reaction (Figs.
2c and 2d). Vacuolization was first recognized in the
neuropil, presumably resulting in neuronal deafferenta-
tion, and became later apparent in neuronal and glial
perikarya (Fig. 2c). The first signs of neuronal pathology
were chromatolysis and swelling of nerve cell somata
and axons. Immunostaining for neuron-specific enolase
confirmed that neuronal necrosis was mostly preceded
by cellular swelling (Fig. 3a), although degeneration by
cellular shrinking could also be detected (not shown).
Occasionally, binucleated neurons representing reactive
cell forms were seen. The degree of local astrocytosis
was moderate to prominent as shown by glial fibrillary
acid protein immunostaining (Fig. 3b). In addition to hy-
pertrophic, sometimes binucleated astrocytes, many
swollen, vacuolated, or decaying astrocytes, could be
identified. Focal reduction of immunoreactivity for myelin
basic protein was due to oligodendrocytic degeneration
and/or heavy vacuolization of myelinated axons (Fig. 3c).
Focal microglial or macrophage reaction was only mod-
erate in mice from both groups. As evidenced by labeling
with isolectin B4 (14), some typical macrophages of prob-
ably perivascular origin accumulated in the periphery
and center of the lesions (Fig. 3d). Small blood vessels in
the spongiform foci exhibited swollen endothelium and
were ensheathed by hypertrophic astrocytic foot pro-
cesses. In some cases, the lesional foci seemed to be
angiocentric.
These similarities in histopathology, as well in disease
latency and incidence, support the hypothesis that the
Mo-AmphoV and Mo-10A1V induce neurodegeneration
by a common pathogenic mechanism. Two ecotropic
MuLV variants (Cas-Br-E and the ts1 Mo-MuLV TB) in-
duce a spongiform encephalomyelopathy similar to that
described here (15–18); however, neurodegeneration is
not a characteristic of ecotropic viruses in general. Sim-
ilarly, spongiform neurodegeneration also is not a hall-
mark of any of the known polytropic MuLV recombinants
(19, 20). In contrast, both members of the two MuLV
interference groups (amphotropic and 10A1) that use
phosphate symporters as cellular receptors induce a
strikingly similar spongiform encephalomyelopathy. Fur-
thermore, this is not dependent on the Mo-MuLV back-
bone, as wild-type 10A1 induces a similar disease but
with different kinetics (unpublished results). Sequences
within the env gene that determine receptor specificity
thus are most likely responsible for the neuropathoge-
nicity of these viruses.
What role might virus–receptor interaction play in Mo-
AmphoV or Mo-10A1V induced spongiform encephalo-
myelopathy? Conceivably, binding of SUgp70 to its recep-
tor may be directly involved in neurodegeneration by
disrupting the normal function of the phosphate sym-
porter in the CNS. Studies have shown that phosphate
transport levels are reduced by 50–60% in NIH 3T3 cells
after infection with amphotropic virus (21). Even a minor
reduction in phosphate levels may be critical to the
homeostasis of neurons or the cells that support them.
The high expression levels of both Pit1 and Pit2 ob-
served in the brain may be indicative of the importance
of these transporters in CNS function (4, 21).
As an alternative to a direct role in neurodegeneration,
the importance of Env–receptor interaction may be re-
lated to targeting the virus into the CNS to either a
specific cell type or during a critical, defined window of
development. Support of the latter theory comes from
both the known age restriction of virus-induced neuro-
degeneration (1 and references therein) and studies of
the Cas-Fr-E recombinant (22, 23). The latter studies
have demonstrated that mutations that increase virus
spread outside of the CNS during early stages of infec-
tion, in this case by expression of an altered glycosylated
Gag protein, dramatically affects the latency and severity
of neurodegenerative disease. Effective infection of a
target cell outside of the CNS thus could be a critical
parameter that determines the neuropathogenicity of
these virus types. We are performing studies to deter-
mine the target cells of these two virus types both in and
outside of the CNS and to compare virus infection kinet-
ics among polytropic, ecotropic, and amphotropic Mo-
MuLV recombinants.
FIG. 2. Neuropathology of DDD mice infected with Mo-AmphoV or Mo-10A1V. (A) Mo-AmphoV-induced, symmetrical brainstem lesions are
preferentially located in the central parts of the medulla oblongata. fr indicates formatio reticularis. Spongy alterations of the trapezoid body (ct) and
lateral lemniscus are clearly visible. (B) Mo-10A1V-induced brainstem lesions are preferentially located in the medullary center of the cerebellar
hemispheres (*). Trapezoid body (ct), lateral lemniscus, and related structures are also affected. (C) In early stages of the pathological process in both
Mo-10A1V- and Mo-AmphoV-infected mice, vacuolization of the tissue is predominantly present in the neuropil, leading to loss of cell contact between
neurons and cell processes (arrows), as depicted here in Mo-10A1-infected tissue. The arrowhead indicates a swollen neuron with marginalization
of Nissl bodies. (D) Final stages of the disease are characterized by a gross spongy state, loss of neurons, and astrocytosis (arrows). Stains were
hematoxylin and eosin (A and B) and cresyl violet (C and D). Magnification: 153 (A and B) and 2503 (C and D).
FIG. 3. Immunophenotyping of cell types involved in Mo-10A1V-induced spongiform encephalomyelopathy of DDD mice. (A) Immunostaining for
neuron-specific enolase reveals positively tagged swollen nerve cells (arrows) and some vacuoles with a positive antibody decoration at their
periphery (*). However, the majority of vacuoles is negative. (B) Glial fibrillary acid protein immunostaining shows activated (arrowhead) and swollen,
degenerating (arrows) astrocytes. Many, but not all, vacuoles are lined by the reaction product of the immunolabel. (C) Myelin basic protein
immunostaining shows antibody decoration of vacuoles, demonstrating vacuolization of axons, myelin sheaths, or both. Arrows indicate oligoden-
drocytic somata. (D) Binding of isolectin B4 of GSI to infiltrating macrophages (arrows) in lesioned brain tissue. Magnification: 2503 (A and D) and
4003 (B and C).
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The work presented here demonstrates that the sub-
stitution of env sequences with that of amphotropic or
10A1 sequence imparts neurovirulence to Mo-MuLV. The
use of phosphate symporters by both viruses to gain
entry into the cell implies that this may be a critical
parameter in the altered diseased specificity. This work
has important safety implications for the clinical use of
retroviral pseudotypes, such as amphotropic and 10A1
MuLVs, as well as GALV, that use phosphate transport-
ers for cell entry. The risk of direct injection of such
pseudotypes in the CNS, as currently being done in
several gene therapy protocols, may have been under-
estimated (1, 24).
Virus production, titration, and infection protocol
SC1 fibroblasts used for virus production were estab-
lished by infection with cellular supernatants from either
NIH 3T3 or SC1 fibroblasts transfected with a molecular
clone of Mo-10A1V or Mo-AmphoV, respectively. In both
recombinant virus genomes, the sequence between the
SalI site in the IN coding region of the pol gene and the
ClaI site in the TM coding region of the env gene of
Mo-MuLV has been replaced with that of either 10A1 or
A-MuLV cl 4070 (1, 5). Virus titers were determined by
end-point dilution (1:5) and immunohistochemical detec-
tion of the CAp30, using a modification of a previously
described method (25). DDD mice (Fv-2s, inbred), bred in
the Heinrich-Pette-Institut animal quarters, were infected
intraperitoneally within 24–48 h after birth with 50 ml of
virus-containing supernatant with virus titers of 4 3 105
CFU/ml.
Histopathology and immunohistology of infected mice
Brains and segments of spinal cords were fixed in situ
in the dissected neurocrania and vertebral columns as
previously described (1). Cellular determinants in the
CNS lesions were examined in paraffin sections using
standard staining procedures (hematoxylin and eosin,
cresyl violet) and the avidin–biotin–peroxidase or alka-
line phosphatase method (26). For antigen detection,
paraffin sections were treated with a commercial target
unmasking fluid (TUF; Dianova, Hamburg, Germany) at
90°C in a microwave oven before incubation with the
diluted primary antibodies, which was done overnight at
4°C. As secondary overlays, biotin-conjugated F(ab9)2
fragments of immunoaffinity-purified sheep anti-rabbit
IgG (Sigma, Deisenhofen, Germany) were used and sub-
sequently detected with streptavidin-biotinylated peroxi-
dase complexes (DAKO Diagnostika, Hamburg, Germa-
ny). Peroxidase activity was detected with H2O2 and
3,3-diaminobenzidine-tetrahydrochloride (Fluka, Buchs,
Switzerland). Counterstaining of nuclei was done with
hemalum (Sigma). Neurons, astrocytes, myelin sheaths,
and macrophages/microglia were immunostained by
use of polyclonal antibodies against neuron-specific
enolase (DAKO Diagnostika), glial fibrillary acid protein
(DAKO Diagnostika), myelin basic protein (DAKO Diag-
nostika), and biotinylated isolectin B4 of Griffonia sim-
plicifolia lectin I (14) (Vector Laboratories, Burlingame,
CA), respectively.
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